Abstract

Pure erythroid leukemia (PEL) is rare hematopoietic neoplasm characterized by uncontrolled proliferation of immature erythroid precursors – mainly abnormal proery-throblasts – comprising at least 80% of bone marrow cells. In this paper, I present a case of 48 years old patient, who presented with pancytopenia and circulating erythroblast in peripheral blood after long history of alcohol abuse. Bone marrow examination revealed hypercellular marrow which is markedly infiltrated with immature erythroid precursors. An expanded panel of immunophenotyping markers has confirmed the diagnosis of PEL. Cytogenetics analysis detected a complex karyotype with multiple chromosomal abnormalities and a novel translocation, t(8;9) (p11.2;q12), which has not been reported in acute myeloid leukemia (AML) in the past. The patient was treated with standard AML chemotherapy but he did not show an optimal response and passed away. An updated and short review about various aspects of PEL has been made with special focus on immunophenotyping and genetic studies.

Highlights

  • Methods and investigationsHematological investigation revealed hemoglobin of 51 g/L (120-160 g/L), red blood cells (RBC) 2.15×1012/L (4.2-5.5×1012/L), mean corpuscular volume 88 fl (78-97 fl) and mean corpuscular hemoglobin 28 pg (27-32 pg)

  • Liver function tests were within normal limits

  • The patient was treated with a standard induction (7+3) chemotherapy regimen consisting of daunorubicin 45 mg/m2 daily for 3 days and cytarabine 100 mg/m2 daily continuous infusion for 7 days

Read more

Summary

Methods and investigations

Hematological investigation revealed hemoglobin of 51 g/L (120-160 g/L), red blood cells (RBC) 2.15×1012/L (4.2-5.5×1012/L), mean corpuscular volume 88 fl (78-97 fl) and mean corpuscular hemoglobin 28 pg (27-32 pg). Leukocytes were 2.01×109/L with 3% blasts, myelocytes 3%, neutrophils 19%, monocytes 8%, basophils 1% and 67% lymphocytes.

Hospital course
Findings
Treatment and prognosis
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call